Related party note receivable from mink therapeutics, inc
5,179
Prepaid expenses
785
Assets held for sale
121,554
Other current assets
1,089
Total current assets
133,436
Property, plant and equipment, gross
62,938
Plant and equipment, accumulated amortization and depreciation
47,468
Property, plant and equipment, net of accumulated amortization and depreciation of 47,468 and 72,553 at december 31, 2025 and 2024, respectively
15,470
Operating lease right-of-use assets
7,744
Goodwill
24,092
Acquired intangible assets, net of accumulated amortization of 17,325 and 16,986 at december 31, 2025 and 2024, respectively
3,037
Equity method investment in mink therapeutics, inc
24,277
Due from related parties (mink therapeutics, inc.)
15,435
Other long-term assets
3,307
Total assets
226,798
Current portion, long-term debt
44,655
Current portion, liability related to sale of future royalties and milestones
109,323
Current portion, deferred revenue
0
Current portion, operating lease liabilities
1,034
Accounts payable
82,987
Accrued liabilities
34,223
Liabilities held for sale
50,738
Other current liabilities
529
Total current liabilities
323,489
Long-term debt, net of current portion
0
Liability related to sale of future royalties and milestones, net of current portion
169,660
Deferred revenue, net of current portion
1,143
Operating lease liabilities, net of current portion
10,108
Other long-term liabilities
259
Series a-1 convertible preferred stock 31,620 shares designated, issued, and outstanding at december 31, 2025 and 2024 liquidation value of 34,317 and 34,101 at december 31, 2025, and 2024, respectively
0
Common stock, par value 0.01 per share 800,000,000 shares authorized at december 31, 2025 and 2024 35,320,397 shares and 23,634,670 shares issued and outstanding at december 31, 2025 and 2024, respectively
353
Additional paid-in capital
1,911,740
Accumulated other comprehensive loss
-439
Accumulated deficit
-2,182,765
Total stockholders' deficit attributable to agenus inc
-271,111
Non-controlling interest
-6,750
Total stockholders' deficit
-277,861
Total liabilities, convertible preferred stock and stockholders' deficit
226,798
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Time Plot
Show the time plot by selecting a row from the table.